Johnson & Johnson Innovation is first collaborator.

Killian Award recipient Stephen Lippard describes his work on platinum-based chemotherapy agents

As some countries and companies roll out new rules to limit animal testing in pharmaceutical products designed for people, scientists are stepping in with a new way to test therapeutic drug candidates and determine drug safety and drug interactions — without using animals. The development of “chemosynthetic livers,” which could dramatically alter how drugs are made, was presented at the 247^th National Meeting & Exposition of the American Chemical Society (ACS), the world’s largest scientific society.

The William K. Warren Foundation of Tulsa, Okla., has made a $3.5 million gift to the University of Notre Dame that, combined with a previous gift valued at $6.5 million, will endow the creation of The Warren Family Research Center for Drug Discovery and Development in the College of Science.

Scientists from the University of Sheffield have developed a novel antibody-based therapy which targets the progression of life threatening kidney fibrosis.

Scientists at The Scripps Research Institute (TSRI) have demonstrated the power of a new drug discovery technique, which allows them to find—relatively quickly and cheaply—antibodies that have a desired effect on cells. The TSRI scientists used the technique to discover two antibodies that protect human cells from a cold virus.

Scripps Research Institute Scientists Use Method to Identify Compound with Promise for Obesity-Linked Diabetes.

Probing New Ideas: Dr. Les Satin's lab provides an environment in which science is the main motivation

Bioengineers from the University of California, San Diego have created a new method for analyzing RNA transcripts from samples of 50 to 100 cells. The approach could be used to develop inexpensive and rapid methods for diagnosing cancers at early stages, as well as better tools for forensics, drug discovery and developmental biology.

In the battle against antibiotic resistant bacteria, McMaster University researchers have found resistance itself is a successful pathway for discovering new antibiotic drugs.